AMI Investment Management Inc. Acquires 1,096 Shares of Stryker Co. (NYSE:SYK)

AMI Investment Management Inc. increased its holdings in Stryker Co. (NYSE:SYK - Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,345 shares of the medical technology company's stock after purchasing an additional 1,096 shares during the quarter. Stryker makes up 1.2% of AMI Investment Management Inc.'s investment portfolio, making the stock its 26th biggest holding. AMI Investment Management Inc.'s holdings in Stryker were worth $3,725,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Edgestream Partners L.P. bought a new stake in shares of Stryker in the 2nd quarter valued at $369,000. AE Wealth Management LLC grew its holdings in Stryker by 101.8% during the 2nd quarter. AE Wealth Management LLC now owns 3,414 shares of the medical technology company's stock worth $1,162,000 after acquiring an additional 1,722 shares during the period. Pacer Advisors Inc. raised its position in shares of Stryker by 8.4% in the 2nd quarter. Pacer Advisors Inc. now owns 27,438 shares of the medical technology company's stock worth $9,336,000 after acquiring an additional 2,122 shares in the last quarter. Sei Investments Co. lifted its stake in shares of Stryker by 4.0% in the 2nd quarter. Sei Investments Co. now owns 168,336 shares of the medical technology company's stock valued at $57,271,000 after purchasing an additional 6,443 shares during the period. Finally, Thrivent Financial for Lutherans boosted its position in shares of Stryker by 69.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 87,244 shares of the medical technology company's stock valued at $29,685,000 after purchasing an additional 35,833 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Stryker

In other Stryker news, CEO Kevin Lobo sold 57,313 shares of the business's stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $368.70, for a total value of $21,131,303.10. Following the sale, the chief executive officer now directly owns 100,027 shares in the company, valued at $36,879,954.90. The trade was a 36.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 5.90% of the company's stock.

Analysts Set New Price Targets

SYK has been the topic of several recent analyst reports. Citigroup boosted their price target on Stryker from $411.00 to $450.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. StockNews.com raised shares of Stryker from a "hold" rating to a "buy" rating in a research note on Thursday, January 9th. Wells Fargo & Company lifted their price target on shares of Stryker from $405.00 to $427.00 and gave the company an "overweight" rating in a research note on Wednesday, December 11th. Canaccord Genuity Group increased their price objective on shares of Stryker from $360.00 to $400.00 and gave the stock a "buy" rating in a research report on Wednesday, October 30th. Finally, Morgan Stanley raised Stryker from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $370.00 to $445.00 in a research report on Monday, December 2nd. Four investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company's stock. According to data from MarketBeat, Stryker presently has an average rating of "Moderate Buy" and a consensus target price of $405.80.

Stryker Stock Performance

Shares of Stryker stock traded up $2.12 during mid-day trading on Monday, hitting $383.91. 1,727,106 shares of the stock were exchanged, compared to its average volume of 1,070,245. The company has a market capitalization of $146.35 billion, a P/E ratio of 41.15, a P/E/G ratio of 2.51 and a beta of 0.95. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.22 and a current ratio of 1.91. The company has a 50-day simple moving average of $375.51 and a 200 day simple moving average of $359.17. Stryker Co. has a 12 month low of $307.23 and a 12 month high of $398.20.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.77 by $0.10. Stryker had a return on equity of 23.07% and a net margin of 16.34%. The business had revenue of $5.49 billion for the quarter, compared to analysts' expectations of $5.37 billion. During the same quarter in the previous year, the firm earned $2.46 earnings per share. The business's revenue was up 11.9% on a year-over-year basis. Sell-side analysts anticipate that Stryker Co. will post 12.06 earnings per share for the current fiscal year.

Stryker Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.84 dividend. This is a positive change from Stryker's previous quarterly dividend of $0.80. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.36 annualized dividend and a yield of 0.88%. Stryker's payout ratio is currently 36.01%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.